6 Stocks Losing Top Investor Support

By Motley Fool Staff
August 26, 2009 | Comments (1)

Recs

3

"Bull markets are born on pessimism, grow on skepticism, mature on optimism, and die on euphoria. The time of maximum pessimism is the best time to buy, and the time of maximum optimism is the best time to sell." -- Sir John Templeton

Just as it makes sense to research the stocks attracting top investors, it's equally important to figure out why smart money is leaving other investments. Using Motley Fool CAPS, the Fool's 135,000-member-strong investing community, we can see which stocks are losing support from CAPS All-Star players.

A sudden decrease in interest from top-rated investors could signal that the stock is losing steam, which might make it an awful stock to avoid for now. At the very least, such drops should signal that further research is in order.

Here are six stocks receiving less support from CAPS All-Stars over the past month:

Company

Industry

% Change in All-Star Bulls From 7/27 to 8/26

CAPS Rating (out of 5)

CAPS Research

China Biotics Inc (Nasdaq: CHBT)

Biotechnology

(24%)

 3 Stars CHBT

Apco Argentina, Inc. (Nasdaq: APAGF)

Oil, Gas and Consumable Fuels

(23%)

 3 Stars APAGF

CyberSource Corp (Nasdaq: CYBS)

IT Services

(21%)

 3 Stars CYBS

DepoMed, Inc. (Nasdaq: DEPO)

Pharmaceuticals

(20%)

 4 Stars DEPO

CEVA, Inc. (Nasdaq: CEVA)

Semiconductors and Semiconductor Equipment

(20%)

 4 Stars CEVA

Cypress Bioscience, Inc. (Nasdaq: CYPB)

Pharmaceuticals

(20%)

 3 Stars CYPB

Source: Motley Fool CAPS, as of August 26, 2009

Come join us on CAPS, absolutely free, to learn more about these and countless other interesting stock ideas. Sign up for free.

Like this article? Get our best articles delivered direct to your inbox at no cost. Sign up for Foolwatch Weekly by entering your email below.

No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today’s market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool Pro, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 28, 2009, at 9:50 AM, rwpaules wrote:

    In my opinion, Depomed isn't losing support due to anything other than a lack of news. There are ongoing trials for promising therapies, and we won't know for some time whether those trials will meet a satisfactory endpoint. I'm still bullish on the stock.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 971941, ~/Articles/ArticleHandler.aspx, 11/23/2009 4:26:06 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
An Open Letter to the Federal Reserve

By The Motley Fool

An Open Letter to the Federal Reserve

Related Tickers

11/20/2009 4:00 PM
APAGF $22.92 Up +0.10 +0.44%
Apco Argentina, In… CAPS Rating: ***
CEVA $11.19 Up +0.11 +0.99%
CEVA, Inc. CAPS Rating: ***
CHBT $14.97 Up +0.17 +1.15%
China Biotics Inc CAPS Rating: *****
CYBS $16.68 Down -0.17 -1.01%
CyberSource Corp CAPS Rating: **
CYPB $5.53 Down -0.01 -0.18%
Cypress Bioscience… CAPS Rating: ***
DEPO $3.30 Up +0.03 +0.92%
DepoMed, Inc. CAPS Rating: **

Community: Investing Wiki

Term Of The Hour

Proxy statement: The Proxy Statement: DEF-14A The proxy statement is the notice of the annual general meeting of shareholders filed with the Securities and Exchange Commission. For researchers, it is an essential addition to the 10-K in that it gives us an insight into the workings and intentions of senior executives and the board of directors. The proxy includes the names of directors standing for election,…

Want to learn more or edit this definition?
Click here to read more!